Valeant Pharmaceuticals
-
Bausch Health announces $1.21 billion settlement over stock plungeBausch Health Companies Inc. says it will pay more than $1 billion to settle a lawsuit over a stock plunge that hit investors about four years ago.HealthDec 16, 2019
-
Jeff Sessions seeks resignations of 46 Obama-era U.S. attorneysU.S. Attorney General Jeff Sessions abruptly asked the remaining 46 chief federal prosecutors left over from the Obama administration to resign on Friday.Mar 10, 2017
-
Canadian company’s story shows why Trump might succeed in lowering drug pricesDonald Trump's tough talk on drug prices may force the pharmaceutical industry to abandon questionable financial engineering practices.MoneyFeb 3, 2017
![]()
-
Canada’s highest-paid CEOs make 193 times the average wage: reportCanada's top-paid 100 CEOs make an average of $9.5 million a year, according to a study by the Canadian Centre for Policy Alternatives.CanadaJan 3, 2017
![]()
-
Valeant Pharmaceuticals shares surge 25 per centDespite posting its biggest one-day share gain Tuesday, the new CEO of struggling drugmaker Valeant Pharmaceuticals says the company could eventually undergo a rebranding.MoneyAug 9, 2016
![]()
-
Valeant offers discounts for two drugsValeant Pharmaceuticals says it is offering rebates on the price of two heart drugs that have come under scrutiny by the U.S. Congress.MoneyMay 16, 2016
![]()
-
US lawmakers blast Canadian pharma company Valeant for price-gouging tacticsAmerican lawmakers accused Canadian drugmaker Valeant Pharmaceuticals of gouging patients to reward Wall Street investors at a hearing Wednesday.Apr 27, 2016
![]()
-
Lawyer ‘manufacturing’ Cold-FX case: drug makerThe lawyer pushing for a class-action lawsuit over the alleged shortcomings of a popular cold and flu remedy is manufacturing a case with no real complainants, a court has heard.CanadaApr 6, 2016
![]()
-
Makers of Cold-FX in B.C. court to fight allegations it misled consumersThe makers of Cold-fX are in court today fighting allegations they ignored their own research and misled consumers about the short-term effectiveness of the popular cold and flu remedy.CanadaApr 4, 2016
![]()
-
Valeant facing SEC probe as drugmaker’s miseries mountValeant Pharmaceuticals is entangled in an SEC investigation to compound the drugmaker's headaches as it grapples with questions about its pricing practices, finances and CEO's health.MoneyFeb 29, 2016
![]()
